Cargando...

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer

ErbB2 is a type of receptor tyrosine kinase, which is known to be involved in tumorigenesis, tumor aggressiveness, and clinical outcome. ErbB2-targeting therapy using therapeutic antibodies has been successful in breast cancer treatment. However, the need for repeated treatments and the high cost ar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmaceutics
Autores principales: Ueno, Sho, Kim, Min Woo, Lee, Gibok, Park, Yong Il, Niidome, Takuro, Lee, Ruda
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356551/
https://ncbi.nlm.nih.gov/pubmed/32599712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12060585
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!